CVRS - Corindus Vascular Robotics Stock Price, News & Analysis

$1.15 0.07 (6.48 %)
(As of 11/24/2017 02:40 AM ET)
Previous Close$1.08
Today's Range$1.03 - $1.24
52-Week Range$0.40 - $2.25
Volume1.12 million shs
Average Volume723,156 shs
Market Capitalization$238.42 million
P/E RatioN/A
Dividend YieldN/A
Beta20.14

About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics logoCorindus Vascular Robotics, Inc. is engaged in robotic-assisted vascular interventions. The Company's CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System it brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. It operates through the development, marketing and sales of robotic-assisted vascular interventions segment. The CorPath System enables the robotic-assisted control of coronary guidewires and balloon/stent devices from the safety of a radiation-protected, ergonomic interventional cockpit. The CorPath System consists of two components: a bedside unit and an interventional cockpit.


Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorN/A
SymbolNYSEAMERICAN:CVRS
  • Previous Symbol: NYSEMKT:CVRS
  • CUSIPN/A

    Debt

    Debt-to-Equity RatioN/A
    Current RatioN/A
    Quick RatioN/A

    Price-To-Earnings

    Trailing P/E RatioN/A
    Forward P/E RatioN/A
    P/E GrowthN/A

    Sales & Book Value

    Annual SalesN/A
    Price / SalesN/A
    Cash FlowN/A
    Price / CashN/A
    Book ValueN/A
    Price / BookN/A

    Dividend

    Annual DividendN/A
    Dividend YieldN/A

    Profitability

    Trailing EPS($0.24)
    Net IncomeN/A
    Net Margins-372.63%
    Return on Equity-94.27%
    Return on Assets-75.51%

    Miscellaneous

    EmployeesN/A
    Outstanding Shares188,700,000

    Frequently Asked Questions for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

    What is Corindus Vascular Robotics' stock symbol?

    Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."

    How were Corindus Vascular Robotics' earnings last quarter?

    Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) announced its quarterly earnings results on Tuesday, November, 7th. The medical equipment provider reported ($0.04) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.05) by $0.01. The medical equipment provider earned $2.43 million during the quarter, compared to analyst estimates of $3.60 million. Corindus Vascular Robotics had a negative return on equity of 94.27% and a negative net margin of 372.63%. View Corindus Vascular Robotics' Earnings History.

    Where is Corindus Vascular Robotics' stock going? Where will Corindus Vascular Robotics' stock price be in 2017?

    2 equities research analysts have issued 1 year target prices for Corindus Vascular Robotics' shares. Their predictions range from $3.00 to $3.00. On average, they anticipate Corindus Vascular Robotics' stock price to reach $3.00 in the next year. View Analyst Ratings for Corindus Vascular Robotics.

    Are investors shorting Corindus Vascular Robotics?

    Corindus Vascular Robotics saw a increase in short interest in October. As of October 31st, there was short interest totalling 10,628,907 shares, an increase of 0.2% from the October 13th total of 10,610,826 shares. Based on an average daily volume of 976,360 shares, the short-interest ratio is presently 10.9 days. Approximately 11.7% of the company's stock are sold short.

    Who are some of Corindus Vascular Robotics' key competitors?

    Who are Corindus Vascular Robotics' key executives?

    Corindus Vascular Robotics' management team includes the folowing people:

    • Jeffrey C. Lightcap, Independent Chairman of the Board (Age 57)
    • Mark J. Toland, President, Chief Executive Officer, Director (Age 46)
    • David W. Long, Chief Financial Officer, Senior Vice President, Treasurer, Secretary (Age 46)
    • John K. Bakewell, Director (Age 55)
    • Louis A Cannon M.D., Director
    • Gerard Winkels, Director (Age 59)
    • Hillel Bachrach, Independent Director (Age 70)
    • Jeffrey Gold, Independent Director (Age 68)

    Who owns Corindus Vascular Robotics stock?

    Corindus Vascular Robotics' stock is owned by a number of of retail and institutional investors. Top institutional investors include Essex Investment Management Co. LLC (0.43%) and Schwab Charles Investment Management Inc. (0.20%). Company insiders that own Corindus Vascular Robotics stock include Healthcor Management, LP, Jeffrey Gold, Louis A Cannon and Philips Nv Koninklijke. View Institutional Ownership Trends for Corindus Vascular Robotics.

    Who bought Corindus Vascular Robotics stock? Who is buying Corindus Vascular Robotics stock?

    Corindus Vascular Robotics' stock was acquired by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC and Schwab Charles Investment Management Inc.. Company insiders that have bought Corindus Vascular Robotics stock in the last two years include Healthcor Management, LP, Jeffrey Gold and Louis A Cannon. View Insider Buying and Selling for Corindus Vascular Robotics.

    How do I buy Corindus Vascular Robotics stock?

    Shares of Corindus Vascular Robotics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

    What is Corindus Vascular Robotics' stock price today?

    One share of Corindus Vascular Robotics stock can currently be purchased for approximately $1.15.

    How big of a company is Corindus Vascular Robotics?

    Corindus Vascular Robotics has a market capitalization of $238.42 million.

    How can I contact Corindus Vascular Robotics?

    Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.


    MarketBeat Community Rating for Corindus Vascular Robotics (CVRS)

    Community Ranking:  2.1 out of 5 (star star)
    Outperform Votes:  128 (Vote Outperform)
    Underperform Votes:  182 (Vote Underperform)
    Total Votes:  310
    MarketBeat's community ratings are surveys of what our community members think about Corindus Vascular Robotics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

    Analyst Ratings

    Analysts' Consensus Rating for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

      (How are Consensus Ratings Calculated?)
    Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
    Consensus Rating:Buy (Score: 3.00)
    Consensus Price Target: $3.00

    Consensus Price Target History for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

    Price Target History for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

    Analysts' Ratings History for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

    Show:
    DateFirmActionRatingPrice TargetDetails
    8/9/2017Cowen IncSet Price TargetBuy$3.00View Rating Details
    5/15/2017B. RileyReiterated RatingBuy$3.00View Rating Details
    4/20/2016Sterne Agee CRTReiterated RatingBuy$3.00View Rating Details
    1/19/2016Stifel NicolausLower Price TargetBuy$6.00 -> $4.00View Rating Details
    (Data available from 11/24/2015 forward)

    Earnings

    Earnings History and Estimates Chart for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

    Earnings by Quarter for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

    Earnings History by Quarter for Corindus Vascular Robotics (NYSEAMERICAN CVRS)

    DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
    11/7/2017Q3 2017($0.05)($0.04)$3.60 million$2.43 millionViewN/AView Earnings Details
    8/8/2017Q2 2017($0.05)($0.04)$3.10 million$2.26 millionViewListenView Earnings Details
    5/9/2017Q1 2017($0.05)($0.07)$1.59 million$0.78 millionViewListenView Earnings Details
    3/15/2017Q4 2016($0.07)($0.08)$0.73 million$0.54 millionViewN/AView Earnings Details
    11/8/2016Q316($0.06)($0.07)$1.27 million$0.69 millionViewListenView Earnings Details
    3/8/2016Q415($0.05)($0.06)$0.62 million$0.83 millionViewN/AView Earnings Details
    11/12/2015Q315($0.06)($0.06)$0.70 million$0.21 millionViewListenView Earnings Details
    (Data available from 1/1/2011 forward)

    Estimates

    Earnings Estimates for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

    No earnings estimates for this company have been tracked by MarketBeat.com

    Dividends

    Dividend History for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)
    No dividend announcements for this company have been tracked by MarketBeat.com

    Insider Trades

    Insider Trading and Institutional Ownership History for Corindus Vascular Robotics (NYSEAMERICAN CVRS)

    Insider Trades by Quarter for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)
    Institutional Ownership by Quarter for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

    Insider Trades by Quarter for Corindus Vascular Robotics (NYSEAMERICAN CVRS)

    Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
    11/13/2017Louis A CannonDirectorBuy23,801$0.81$19,278.81View SEC Filing  
    3/22/2017Louis A CannonDirectorBuy27,000$1.30$35,100.00View SEC Filing  
    2/28/2017Healthcor Management, L.P.Major ShareholderBuy7,557,436$0.66$4,987,907.76View SEC Filing  
    11/25/2016Jeffrey GoldDirectorBuy10,000$0.76$7,600.00View SEC Filing  
    (Data available from 1/1/2013 forward)

    Headlines

    Latest Headlines for Corindus Vascular Robotics (NYSEAMERICAN CVRS)

    Source:
    DateHeadline
    ETFs with exposure to Corindus Vascular Robotics, Inc. : November 20, 2017ETFs with exposure to Corindus Vascular Robotics, Inc. : November 20, 2017
    finance.yahoo.com - November 20 at 6:42 PM

    Social Media

    Social activity is not available for this stock.

    Financials

    Chart

    Corindus Vascular Robotics (NYSEAMERICAN CVRS) Chart for Friday, November, 24, 2017
    Loading chart…

    This page was last updated on 11/24/2017 by MarketBeat.com Staff

    Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.